June 9, 2022
On June 9, 2022, Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA) will host the second BLUE KNIGHT™ Symposium. Join us for a global conversation with innovators, investors, partners and thought leaders to discover and accelerate next-gen potential solutions for future pandemics, emerging infectious diseases, and other known and unknown health threats.
Be sure to register for a full day of programming streaming virtually from JLABS @ Washington, DC, and other sites globally. Subscribe for updates.
Blue Knight is a joint initiative between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA), a component of the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services. This collaboration aims to stimulate the innovation and incubation of science and technologies that may improve health security and response by supporting companies focused on public health threats and emerging infectious diseases. Find out more about BARDA and its mission at www.PHE.gov/BARDA.